1.98
-0.002(-0.10%)
Currency In USD
| Previous Close | 1.98 |
| Open | 1.94 |
| Day High | 1.99 |
| Day Low | 1.93 |
| 52-Week High | 3.26 |
| 52-Week Low | 1.63 |
| Volume | 24,564 |
| Average Volume | 303,390 |
| Market Cap | 11.46M |
| PE | -1.18 |
| EPS | -1.68 |
| Moving Average 50 Days | 2.07 |
| Moving Average 200 Days | 2.24 |
| Change | -0 |
If you invested $1000 in BioCardia, Inc. (BCDA) 10 years ago, it would be worth $5.08 as of September 03, 2025 at a share price of $1.975. Whereas If you bought $1000 worth of BioCardia, Inc. (BCDA) shares 5 years ago, it would be worth $19.68 as of September 03, 2025 at a share price of $1.975.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D™ Fusion Imaging for Interventional Cardiology
GlobeNewswire Inc.
Aug 13, 2025 12:00 PM GMT
SUNNYVALE, Calif. and UTRECHT, Netherlands, Aug. 13, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, and CART-Tech, B.V.
BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025
GlobeNewswire Inc.
Aug 06, 2025 7:18 PM GMT
SUNNYVALE, Calif., Aug. 06, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate updat
BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP® Cell Therapy for Heart Failure and Helix™ Transendocardial Delivery Catheter
GlobeNewswire Inc.
Aug 04, 2025 10:00 AM GMT
SUNNYVALE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today provides the anticipated timing of reg